Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 01-Sep 2023. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 5266542016 | Bimekizumab (substance) | en | Fully specified name | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 5266543014 | Bimekizumab | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Bimekizumab (substance) | Is a | Monoclonal antibody | true | Inferred relationship | Some | ||
| Bimekizumab (substance) | Is a | Interleukin receptor antagonist | true | Inferred relationship | Some | ||
| Bimekizumab (substance) | Has disposition (attribute) | Interleukin receptor antagonist (disposition) | true | Inferred relationship | Some | ||
| Bimekizumab (substance) | Is a | Immunosuppressant (substance) | true | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Bimekizumab 160 mg/mL solution for injection | Has precise active ingredient | True | Bimekizumab (substance) | Inferred relationship | Some | 1 |
| Bimekizumab 160 mg/mL solution for injection | Has basis of strength substance (attribute) | True | Bimekizumab (substance) | Inferred relationship | Some | 1 |
| Product containing only bimekizumab (medicinal product) | Has active ingredient | True | Bimekizumab (substance) | Inferred relationship | Some | 1 |
| Bimekizumab-containing product | Has active ingredient | True | Bimekizumab (substance) | Inferred relationship | Some | 1 |
| Product containing bimekizumab in parenteral dose form (medicinal product form) | Has active ingredient | True | Bimekizumab (substance) | Inferred relationship | Some | 1 |
| Product containing only bimekizumab in parenteral dose form (medicinal product form) | Has active ingredient | True | Bimekizumab (substance) | Inferred relationship | Some | 1 |
Reference Sets
Description inactivation indicator reference set
FHIR